The effects of TGF‐β on the immune and tumor microenvironment are mediated by NF‐κB and ERK 1/2, which are important regulators of immunoreaction and critical mediators in cancer initiation and progression.74, 75, 76. The gene discussed is NFKB1; the disease is neoplasm.